ArticleFrontiers in oncology2021

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.

Yuan Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.